v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Defined Benefit Plan Disclosure [Line Items]    
Revenues $ 112,399 $ 1,212,264
Cost of revenues (69,121) (573,807)
Gross profit 43,278 638,457
Operating expenses:    
Selling expenses (1,425,833) (3,553)
General and administrative expenses (721,494) (497,544)
Research and development expenses (1,876,571) (50,739)
Total operating expenses (4,023,898) (551,836)
(Loss) income from operations (3,980,620) 86,621
Other income/(loss):    
Foreign exchange gain/(loss) 9,056 (25,486)
Other income/(expense), net 184,706 (57,978)
Total other income/(loss) 193,762 (83,464)
(Loss)/income before income tax expense (3,786,858) 3,157
Income tax expense
Net (loss)/income (3,786,858) 3,157
Other comprehensive loss    
Foreign currency translation adjustment (7,899) (76,902)
Total comprehensive loss $ (3,794,757) $ (73,745)
Weighted average shares outstanding used in calculating basic and diluted loss per share - basic [1] 18,059,109 15,759,109
Weighted average shares outstanding used in calculating basic and diluted loss per share - diluted [1] 18,059,109 15,759,109
(Loss)/income per share - basic [1] $ (0.2097) $ 0.0002
(Loss)/income per share - diluted [1] $ (0.2097) $ 0.0002
Third Parties [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Revenues $ 112,399 $ 1,212,264
Cost of revenues (110,369)
Operating expenses:    
Research and development expenses (885,000) (50,739)
Related Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Cost of revenues (69,121) (463,438)
Operating expenses:    
Research and development expenses $ (991,571)
[1] The Company effected a 1:25 forward stock split on March 31, 2025 and a surrender of 45 out of every 100 shares on June 6, 2025, as a result, the shares issued and outstanding and additional paid in capital presented here are adjusted retroactively.